November 11, 2026 · Menopause (New York, N.Y.) · DOI: 10.1097/GME.0000000000002943

Endometrial thickness and risk of endometrial pathology in women with postmenopausal bleeding: the influence of hormone therapy.

Listen to this summary

This study asked whether endometrial thickness (ET) reliably identifies endometrial cancer or atypical hyperplasia in postmenopausal women with vaginal bleeding, and whether menopausal hormone therapy use changes that performance. In a retrospective cohort of 1,082 women referred to an urgent cancer pathway in a UK hospital, ET showed excellent discrimination in non-users of hormone therapy (AUC 0.925) but poor discrimination in users of continuous combined therapy (AUC 0.597). The authors conclude that ET is a useful triage tool for women not on hormone therapy, while its value as a standalone measure is limited in those on continuous combined therapy, so HT status should guide interpretation and referral.

Collins E M Okoror, Sayantan Sen, Saleh Hazbun, Shreya Thapa, Renu Gurung, Karina Devi Ramdenee, Ayda H Redai

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play